Name: Living with Narcolepsy: Saturday Support Group
Start: 2024-05-04T13:30:00-04:00
End: 2024-05-04T14:30:00-04:00

Jul 20 2022
Avadel Pharmaceuticals: FDA grants tentative approval to LUMRYZ

Posted at Jul 20 2022
h in News by Chris DavisAdvertising

Avadel Pharmaceuticals announced today that the FDA has granted tentative approval to LUMRYZ, a once-at-bedtime investigational formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

Read Article

Print page

Jul 20 2022 Avadel Pharmaceuticals: FDA grants tentative approval to LUMRYZ

2 events, 1

2 events, 1

2 events, 2

2 events, 2

2 events, 3

2 events, 3

1 event, 4

1 event, 4

1 event, 5

1 event, 5

2 events, 6

2 events, 6

0 events, 7

0 events, 7

2 events, 8

2 events, 8

2 events, 9

2 events, 9

2 events, 10

2 events, 10

1 event, 11

1 event, 11

1 event, 12

1 event, 12

1 event, 13

1 event, 13

0 events, 14

0 events, 14

2 events, 15

2 events, 15

2 events, 16

2 events, 16

2 events, 17

2 events, 17

1 event, 18

1 event, 18

1 event, 19

1 event, 19

1 event, 20

1 event, 20

0 events, 21

0 events, 21

2 events, 22

2 events, 22

2 events, 23

2 events, 23

3 events, 24

3 events, 24

1 event, 25

1 event, 25

1 event, 26

1 event, 26

2 events, 27

2 events, 27

Wake Up Narcolepsy 2024 National Summit

Wake Up Narcolepsy 2024 National Summit

Jul 20 2022
Avadel Pharmaceuticals: FDA grants tentative approval to LUMRYZ